Difference between revisions of "TG004181"
Jump to navigation
Jump to search
| Line 4: | Line 4: | ||
|nrt=50.473 | |nrt=50.473 | ||
|ntransition=8 | |ntransition=8 | ||
| − | |pepnrt=use (-0. | + | |pepnrt=use (-0.215) |
|peptide=PE001572 | |peptide=PE001572 | ||
|prt=34.049 | |prt=34.049 | ||
Latest revision as of 17:56, 23 May 2021
| Peptide | K.TQSLLIVNN[H4N4F2]ATNVVIK.V (PE001572) |
|---|---|
| Sequence | TQSLLIVNNATNVVIK |
| Glycans(s) | H4N4F2 (N9) |
| Mod(s) | |
| Molecular Weight | 3,496.654 |
| Charge | 3+ |
| Protein | S (P0DTC2) |
| Spectrum File | MS_50_Covid_spike_trypsin_new2 |
| Method | Orbitrap Fusion-Lumos, DDA (EThcD pd HCD), nano LC-MS/MS |
| Analytical Fraction | No enrichment |
| Sample | SARS-CoV-2 Spike Protein |
Transitions
| Exp. R.T. | Peak R.T. | Norm. R.T. | Prec. m/z | Prec. z | Prod. m/z | Prod. z | Label | %Int |
|---|---|---|---|---|---|---|---|---|
| 34.159 | 34.049 | 50.473 | 1,160.556 | 3+ | 1,930.086 | 1+ | Y[pN] | 14.0 |
| 34.159 | 34.049 | 50.473 | 1,160.556 | 3+ | 965.547 | 2+ | Y[pN] | 12.1 |
| 34.159 | 34.049 | 50.473 | 1,160.556 | 3+ | 1,383.195 | 2+ | Y[pH3N2F] | 10.0 |
| 34.159 | 34.049 | 50.473 | 1,160.556 | 3+ | 1,229.139 | 2+ | Y[pH2N2] | 8.9 |
| 34.159 | 34.049 | 50.473 | 1,160.556 | 3+ | 1,310.166 | 2+ | Y[pH3N2] | 8.6 |
| 34.159 | 34.049 | 50.473 | 1,160.556 | 3+ | 1,484.735 | 2+ | Y[pH3N3F] | 6.0 |
| 34.159 | 34.049 | 50.473 | 1,160.556 | 3+ | 1,565.761 | 2+ | Y[pH4N3F] | 5.6 |
| 34.159 | 34.049 | 50.473 | 1,160.556 | 3+ | 1,067.087 | 2+ | Y[pN2] | 5.4 |
Spectra
6531;EThcD;33.935;6522;1160.563;Byonic:q-value=7.25e-05/GPS:MinICScore=25.876
6533;HCD;33.945;6522;1160.563;
6620;EThcD;34.362;6612;1160.564;Byonic:q-value=0.000139/GPS:MinICScore=6.104
6622;HCD;34.372;6612;1160.564;